Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and β-lactams against gram-positive clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 1, 2002, Pages 234-238

  Bassetti, M ^a   Dembry, L M ^a   Farrel, P A ^a   Callan, D A ^a   Andriole, V T ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CIPROFLOXACIN; GARENOXACIN; GATIFLOXACIN; IMIPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0036135407     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.1.234-238.2002     Document Type: Article

References (16)

1. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
2. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms
3. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus
4. Evaluation of the E test, a novel method of quantifying antimicrobial activity
5. Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers
6. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
7. Ciprofloxacin-resistant Staphylococcus aureus
8. In-vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: Data from the SENTRY Antimicrobial Surveillance Program
9. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and Etest method validation
10. Activity and spectrum of BMS-284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci
11. Comparison of three methods for determination of a single M1C of an antimicrobial agent
12. Antimicrobial activity of gatifloxacin (AM-1155, CG 5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States
13. Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program
14. In vitro properties of the quinolones
15. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone